Literature DB >> 24341638

7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation.

Raghu Raj1, Christophe Biot, Séverine Carrère-Kremer, Laurent Kremer, Yann Guérardel, Jiri Gut, Philip J Rosenthal, Delphine Forge, Vipan Kumar.   

Abstract

A series of twenty piperazine-tethered 7-chloroquinoline-isatin hybrids have been synthesized via either direct nucleophilic substitution or Cu(Ι)Cl-mediated Mannich reaction. These new conjugates were evaluated for their antimalarial and antitubercular efficacy against a chloroquine-resistant strain of Plasmodium falciparum and Mycobacterium tuberculosis, respectively, while the cytotoxic profiles were evaluated against 3T6 cell line, a permanent mouse embryonic fibroblast cell line. The most potent of the test compound with IC50 of 0.22 μm against W2 strain of P. falciparum and 31.62 μm against the embryonic fibroblast cell line (cytotoxicity) displayed a high selective index of 143.73.
© 2013 John Wiley & Sons A/S.

Entities:  

Keywords:  7-chloroquinoline-isatin scaffolds; antimalarial activity; antitubercular activity; cytotoxicity; structure activity relationship

Mesh:

Substances:

Year:  2014        PMID: 24341638     DOI: 10.1111/cbdd.12273

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  10 in total

Review 1.  Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?

Authors:  Drishti Agarwal; Rinkoo D Gupta; Satish K Awasthi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs).

Authors:  Shefali Chowdhary; Amandeep Arora; Vipan Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

3.  Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae).

Authors:  Victor O Fadipe; Nkoana I Mongalo; Andy R Opoku; Preachers M Dikhoba; Tshepiso J Makhafola
Journal:  BMC Complement Altern Med       Date:  2017-06-12       Impact factor: 3.659

4.  Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations.

Authors:  Sherif T S Hassan; Miroslava Šudomová; Kateřina Berchová-Bímová; Shanmugaraj Gowrishankar; Kannan R R Rengasamy
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

5.  1H-1,2,3-triazole tethered isatin-ferrocene conjugates: Synthesis and in vitro antimalarial evaluation.

Authors:  Kewal Kumar; Bruno Pradines; Marilyn Madamet; Rémy Amalvict; Nicolas Benoit; Vipan Kumar
Journal:  Eur J Med Chem       Date:  2014-10-13       Impact factor: 6.514

6.  β-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: synthesis and antimalarial evaluation.

Authors:  Jiri Gut; Philip J Rosenthal; Vipan Kumar
Journal:  Eur J Med Chem       Date:  2014-07-21       Impact factor: 6.514

7.  Visible-Light-Mediated Dearomatisation of Indoles and Pyrroles to Pharmaceuticals and Pesticides.

Authors:  Waldemar Schilling; Yu Zhang; Daniel Riemer; Shoubhik Das
Journal:  Chemistry       Date:  2019-12-05       Impact factor: 5.236

8.  Design, Synthesis and Preliminary Antimicrobial Evaluation of N-Alkyl Chain Tethered C-5 Functionalized Bis-Isatins.

Authors:  Amandeep Singh; Trpta Bains; Hye Jee Hahn; Nicole Liu; Christina Tam; Luisa W Cheng; Jong Kim; Anjan Debnath; Kirkwood M Land; Vipan Kumar
Journal:  Medchemcomm       Date:  2017-09-19       Impact factor: 3.597

9.  A Chemographic Audit of anti-Coronavirus Structure-activity Information from Public Databases (ChEMBL).

Authors:  Dragos Horvath; Alexey Orlov; Dmitry I Osolodkin; Aydar A Ishmukhametov; Gilles Marcou; Alexandre Varnek
Journal:  Mol Inform       Date:  2020-05-14       Impact factor: 4.050

Review 10.  Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery.

Authors:  Rameshwar S Cheke; Vaishali M Patil; Sandip D Firke; Jaya P Ambhore; Iqrar A Ansari; Harun M Patel; Sachin D Shinde; Visweswara Rao Pasupuleti; Md Imtaiyaz Hassan; Mohd Adnan; Adel Kadri; Mejdi Snoussi
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.